Vilket är priset för Algorae Pharmaceuticals Limited (1AI)

Priset för Algorae Pharmaceuticals Limited (1AI) är $0.00846342

Vilket är marknadsvärdet för Algorae Pharmaceuticals Limited (1AI)

Marknadsvärdet för Algorae Pharmaceuticals Limited (1AI) är $17.16M

Algorae Pharmaceuticals Limited (1AI) P/S-tal

Algorae Pharmaceuticals Limited, a company established in 1987 and based in Melbourne, Australia, focuses on pioneering pharmaceutical development. Known as Living Cell Technologies Limited until its rebranding in September 2023, the firm primarily conducts research and innovation in living cell technologies within New Zealand. Its development portfolio includes AI-116, a novel combination treatment pairing donepezil with cannabidiol, designed to address various forms of dementia, such as Alzheimer's disease. Another key candidate is AI-168, a unique blend of a cannabinoid and an existing, off-patent drug component, aimed at managing cardiovascular conditions like hypertension. Additionally, Algorae is progressing with NTCELL, an alginate-encapsulated product for the treatment of Parkinson's disease. The company is also collaborating with the University of New South Wales to create AlgaraeOS, an advanced drug discovery platform that utilizes artificial intelligence protocols and extensive data analytics to optimize drug identification and development processes.

År	P/S-tal	Ändra
Inte tillräckligt med data för de angivna datumen.

År

P/S-tal

Ändra

Inte tillräckligt med data för de angivna datumen.

Företag	P/S-tal	Skillnad i P/S-tal	Land
Vertex Pharmaceuticals Incorporated VRTX.US	10.17	-	US
Argenx SE ARGX.US	10.13	-	NL
CSL Limited CSL.AX	2.95	-	AU
Lonza Group AG LONN.SW	-	-	CH
UCB S.A. UCB.BR	4.74	-	BE

Företag

P/S-tal

Skillnad i P/S-tal

Land